Chronic Granulomatous Disease: A Clinical Survey of 41 Patients from the Iranian Primary Immunodeficiency Registry
Authors:
- Asghar AghamohammadiAAAsghar Aghamohammadi
- Nima RezaeiNRNima Rezaei
- Nikrad ShahnavazNSNikrad Shahnavaz
- Ali Babaei JandaghiAJAli Babaei Jandaghi
- Abolhasan FarhoudiAFAbolhasan Farhoudi
- Zahra PourpakZPZahra Pourpak
- Mostafa MoinMMMostafa Moin
- Mohammad GharagozlouMGMohammad Gharagozlou
- Davoud MansouriDMDavoud Mansouri
- 28 June 2004
- journal article
- Published by S. Karger AG in International Archives of Allergy and Immunology
- Vol. 134 (3) , 253-259
Abstract
Background: Chronic granulomatous disease (CGD) represents a group of inherited disorders of the phagocytic system, involving recurrent infections at different sites, especially the respiratory system. The present study was accomplished in order to determine the clinical spectrum of Iranian patients with CGD. Methods: Forty-one patients (29 males and 12 females) with CGD, who had already been referred to two immunodeficiency referral centers in Iran, were reviewed during a 22-year period (1980–2002). Results: These patients belonged to 34 families, and 56% of them were consanguineous. The median age at the time of study was 12 years (3 months to 22 years). The median age at onset of symptoms was 4 months (1 month to 12 years), and the median diagnostic age was 5.5 years (2 months to 20 years), with a diagnostic delay of 3 years on average. The most common presenting complaint in our CGD patients was lymphadenopathy (seen in 11 patients, 26.8%). The most common manifestations of CGD (in descending order) were lymphadenopathy (75.6%), pulmonary infections (65.9%) and skin involvement (63.4%) during their illness, followed by gastrointestinal (56.1%), skeletal (29.3%), upper respiratory tract (26.8%) and central nervous system (2.4%) involvement. Conclusions: Early diagnosis of the disease is crucial. In view of the possibility of timely treatment, i.e. prophylactic treatment of infection, CGD should be excluded in any patient with unexplained infections or granulomas.Keywords
This publication has 11 references indexed in Scilit:
- Itraconazole to Prevent Fungal Infections in Chronic Granulomatous DiseaseNew England Journal of Medicine, 2003
- Investigating antibody-catalyzed ozone generation by human neutrophilsProceedings of the National Academy of Sciences, 2003
- Hepatic Abscess in Patients With Chronic Granulomatous DiseaseAnnals of Surgery, 2002
- Clinical aspects of chronic granulomatous diseaseCurrent Opinion in Hematology, 2001
- Immunodeficiency Diseases Caused by Defects in PhagocytesNew England Journal of Medicine, 2000
- Chronic Granulomatous Disease: Report on a National Registry of 368 PatientsMedicine, 2000
- Genetic, Biochemical, and Clinical Features of Chronic Granulomatous DiseaseMedicine, 2000
- Chronic granulomatous disease in Japan: Incidence and natural historyPediatrics International, 1999
- Chronic granulomatous disease in adultsThe Lancet, 1996
- Fungal infection in chronic granulomatous diseaseThe American Journal of Medicine, 1981